Ads
related to: plaque psoriasis treatment- Common Side Effect Info
Get Safety Info & Talk To A Doctor
Before Starting This Treatment.
- View Clinical Results
Discover Treatment Effectiveness &
Learn About Patients' Experiences.
- View An Injection Video
Some Patients May Use Prefilled
Syringes. Find Self-Injection Info.
- Sign Up For Updates
Stay Informed About This Treatment
Option By Signing Up For Updates.
- Download A Brochure
Access A Downloadable Resource
For Talking To Your Dermatologist.
- Unique Patient Support
Find Patient Support As Unique As
You And Access A Dedicated Nurse.
- Common Side Effect Info
Search results
Cardinal Capital Management Inc. Sells 3,561 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 8 hours agoCardinal Capital Management Inc. cut its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 1.8% during the 1st quarter, according to the company in its most recent Form 13F filing ...
Drug names: How companies and regulators come up with hundreds of new names every year
Quartz· 2 days agoEverything you need to know about the art and science of drug naming in five minutes or less,...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Morningstar· 3 days agoApproval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study, INSPIRE,1 ...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 1 day agoThis approval is a significant milestone, making Skyrizi now available for four different conditions in the U.S., including psoriatic arthritis, plaque psoriasis& ...
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks· 19 hours agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Imfinzi.
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks· 3 days agoSkyrizi’s approval for the UC indication was based on data from two phase III studies, a 12-week induction study, INSPIRE1 and a 52-week maintenance study, COMMAND2. Skyrizi is already approved ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Garde Capital Inc.
ETF DAILY NEWS· 7 days agoGarde Capital Inc. lowered its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 60.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm ...
AbbVie (NYSE:ABBV) Shares Up 0%
ETF DAILY NEWS· 7 days agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 0% during mid-day trading on Thursday . The company traded as high as $166.45 and last traded at $166.15. ABBV has been the topic ...
Spartan Planning & Wealth Management Sells 194 Shares of Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 4 days agoSpartan Planning & Wealth Management cut its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 15.3% in the fourth quarter, according to the company in its most recent disclosure ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Stableford Capital II LLC
ETF DAILY NEWS· 9 hours agoStableford Capital II LLC decreased its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 6.2% in the 1st quarter, Holdings Channel reports. The firm owned 5,038 shares of the company’s stock ...
Ads
related to: plaque psoriasis treatment